| ID | 57959 |
| JaLCDOI | |
| FullText URL | |
| Author |
Kada, Akiko
Clinical Research Center, NHO Nagoya Medical Center
Fukano, Reiji
Department of Pediatrics, Yamaguchi University Graduate School of Medicine
Mori, Tetsuya
Department of Pediatrics, St. Marianna University School of Medicine Hospital
Kamei, Michi
Department of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences
Tanaka, Fumiko
Department of Pediatrics, Saiseikai Yokohamashi Nanbu Hospital
Ueyama, Junichi
Department of Pediatrics, Tottori University Hospital,
Sekimizu, Masahiro
Department of Pediatrics, NHO Nagoya Medical Center
Osumi, Tomoo
Children’s Cancer Center, National Center for Child Health and Development
Mori, Takeshi
Department of Hematology and Oncology, Children’s Cancer Center, Kobe Children’s Hospital
Koga, Yuhki
Department of Pediatrics, Graduate School of Medical Sciences Kyushu University
Ohki, Kentaro
Department of Pediatric Hematology and Oncology Research, National Center for Child Health and Development
Fujita, Naoto
Department of Pediatrics, Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital
Mitsui, Tetsuo
Department of Pediatrics, Yamagata University Hospital
Saito, Akiko M.
Clinical Research Center, NHO Nagoya Medical Center
Hashimoto, Hiroya
Clinical Research Center, NHO Nagoya Medical Center
Kobayashi, Ryoji
Department of Pediatrics and Adolescence, Sapporo Hokuyu Hospital
|
| Abstract | No standard treatment for relapsed or refractory anaplastic large-cell lymphoma (ALCL) has been established. This study is a multicenter, open-label trial to examine the effectiveness and safety of transplantation with reduced-intensity conditioning (RIC) for patients under 20 years old with relapsed or refractory ALCL. We defined RIC as the administration of fludarabine (30 mg/m2/day) for five days plus melphalan (70 mg/m2/day) for two days and total body irradiation at 4 Gy, followed by allogeneic hematopoietic stem cell transplantation.
|
| Keywords | anaplastic large-cell lymphoma
relapsed/refractory
fludarabine
melphalan
total body irradiation
|
| Amo Type | Clinical Study Protocol
|
| Publication Title |
Acta Medica Okayama
|
| Published Date | 2020-02
|
| Volume | volume74
|
| Issue | issue1
|
| Publisher | Okayama University Medical School
|
| Start Page | 89
|
| End Page | 94
|
| ISSN | 0386-300X
|
| NCID | AA00508441
|
| Content Type |
Journal Article
|
| language |
English
|
| Copyright Holders | CopyrightⒸ 2020 by Okayama University Medical School
|
| File Version | publisher
|
| Refereed |
True
|
| PubMed ID | |
| Web of Science KeyUT | |
| NAID |
